Urinary peptidome and diabetic retinopathy in the DIRECT‐Protect 1 and 2 trials
Author:
Affiliation:
1. Steno Diabetes Center Copenhagen Gentofte Denmark
2. Mosaiques Diagnostics Hannover Germany
3. Institute for Molecular Cardiovascular Research University of Aachen Aachen Germany
4. University of Copenhagen Copenhagen Denmark
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.14634
Reference32 articles.
1. Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery
2. Emerging urine-based proteomic biomarkers as valuable tools in the management of chronic kidney disease
3. Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
4. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial
5. Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Urinary peptides provide information about the risk of mortality across a spectrum of diseases and scenarios;Journal of Translational Medicine;2023-09-24
2. Peptides as “better biomarkers”? Value, challenges, and potential solutions to facilitate implementation;Mass Spectrometry Reviews;2023-06-26
3. Urinary peptides predict future death;2023-05-01
4. Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – A post-hoc analysis of the PRIORITY randomized clinical trial;Journal of Diabetes and its Complications;2023-04
5. Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – a post-hoc analysis of the PRIORITY randomized clinical trial;2022-11-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3